Abolishing advanced grades of ventricular premature beats protects patients with recurring malignant ventricular arrhythmias.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000188:drug therapy*; D003645:Death, Sudden; D004562:Electrocardiography; D006352:Heart Ventricles; D006801:Humans; D012008:Recurrence
D000889:Anti-Arrhythmia Agents